Vídeos de la Dr Rasha Al-Lamee

CRT 2019: ORBITA In Review - Dr Rasha Al-Lamee подробнее

Dr Rasha Al-Lamee (Imperial College London, London, UK) discusses the ORBITA trial. One year later, what has changed? Filmed on site at CRT 2019 by Radcliffe Cardiology Questions: 1. Can you give us a short narrative of the ORBITA story to date? 2. What are the key lessons ORBITA has taught you? 3. What will be ORBITAs legacy? 4. What further research can we expect to see from ORBITA and when? See more videos here : https://www.radcliffecardiology.com/video-gallery radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions. RC Academy : https://www.radcliffecardiology.com/radcliffe-cardiology-academy

AHA 19: Commentary On The ISCHEMIA Trial — Dr Rasha Al-Lamee подробнее

Dr Rasha Al-Lamee (Imperial College London, London, UK) comments on the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches in light of the ORBITA trial. Filmed on site at AHA 2019 by Radcliffe Cardiology. See more videos here : https://www.radcliffecardiology.com/video-gallery RC Academy : https://www.radcliffecardiology.com/radcliffe-cardiology-academy radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions.

Commentary: ISCHEMIA with Rasha Al-Lamee подробнее

Rasha Al-Lamee, MBBS, MRCP, PhD comments on the primary results of the ISCHEMIA trial which were presented during Scientific Sessions 2019. Dr. Al-Lamee is on the faculty of the Medicine, National Heart & Lung Institute at Imperial College London.

Placebo-controlled trials in intervention: Insights from the ORBITA trial подробнее

Dr Rasha Al-Lamee, Interventional Cardiology Consultant at Imperial College Healthcare Trust, outlines the findings of the ORBITA trial which looked at the impact of using heart stents to treat patients with stable angina. Dr Al-Lamee’s explains that while patients with stable chest pain, or angina, who received stent devices had a significant improvement in the blood supply to their heart, they did not have a significant improvement on their symptoms or quality of life compared to a placebo procedure. Dr Al Lamee is using these findinsg to develop a greater understanding of stable angina and to see whether there are subgroups of patients whose angina improves more after stenting.

EuroPCR 2018: ORBITA - Impact Of FFR And IFR On Efficacy Of Coronary Angioplasty - Dr Rasha Al Lamee подробнее

Dr Rasha Al-Lamee (Imperial College, London, UK) discusses ORBITA - A physiology-stratified analysis of the impact of FFR and iFR on efficacy of coronary angioplasty in stable coronary artery disease. Filmed on-site at EuroPCR 2018.

The ORBITA trial - EuroPCR 2018 подробнее

Results from the physiology-stratified analysis of the ORBITA presented at EuroPCR 2018 have great implications for PCI in CAD and beyond – meet the ORBITA PI, R. Al-Lamee as she speaks with W. Wijns …. The content of this video was filmed at EuroPCR 2018, see more videos here: https://www.pcronline.com/Cases-resources-images/Resources/Educational-interviews

TCT 2017 | ORBITA подробнее

Dr. Peter Block interviews presenter Rasha Al-Lamee on a sham-controlled trial of PCI. Visit http://www.acc.org/TCT2017 for full meeting coverage

Results from the ORBITA trial: A study of heart stents in patients with stable angina подробнее

Researchers at Imperial College London have explored the placebo effects of a coronary angioplasty procedure with stents in patients with stable angina for the first time. The initial findings suggest the placebo effect may be larger than previously thought. For more information please visit http://bit.ly/2iompWV

Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina подробнее

This interview with Rasha Al-Lamee from Imperial College London, London, UK discusses Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina at TCT 2017.

Commentary: ISCHEMIA-CKD with Rasha Al Lamee подробнее

Rasha Al-Lamee, MA, MBBS, PhD served as a moderator during the ISCHEMIA session. Here she comments on the Chronic Kidney Disease focus of the ISCHEMIA trial, presented at Scientific Sessions 2019. Dr. Al-Lamee is on the faculty of the Medicine, National Heart & Lung Institute at Imperial College London.